These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8239927)

  • 21. A hospital-wide blind control program for bedside glucose meters.
    Bain OF; Brown KD; Sacher RA; McPherson RA
    Arch Pathol Lab Med; 1989 Dec; 113(12):1370-5. PubMed ID: 2589948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytic goals, concentration relationships, and the state of the art for clinical laboratory precision.
    Ross JW; Lawson NS
    Arch Pathol Lab Med; 1995 Jun; 119(6):495-513. PubMed ID: 7605165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bedside monitoring of blood glucose in hospitals. Speed vs precision and accuracy.
    Watts NB
    Arch Pathol Lab Med; 1993 Nov; 117(11):1078-9. PubMed ID: 8239926
    [No Abstract]   [Full Text] [Related]  

  • 24. Digoxin therapeutic drug monitoring practices. A College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels.
    Howanitz PJ; Steindel SJ
    Arch Pathol Lab Med; 1993 Jul; 117(7):684-90. PubMed ID: 8323428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of errors in laboratory reports. A quality improvement study of the College of American Pathologists' Q-Probes program.
    Howanitz PJ; Walker K; Bachner P
    Arch Pathol Lab Med; 1992 Jul; 116(7):694-700. PubMed ID: 1497440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey to identify potential outcome indicators for a hospital blood glucose monitoring program.
    Collier CP; Houlden RL; Gleeson KA; Patrzykat A; Rhymer SL
    Clin Biochem; 1998 Jun; 31(4):263-8. PubMed ID: 9646950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood culture quality improvement: a College of American Pathologists Q-Probes study involving 909 institutions and 289 572 blood culture sets.
    Schifman RB; Bachner P; Howanitz PJ
    Arch Pathol Lab Med; 1996 Nov; 120(11):999-1002. PubMed ID: 12049115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intralaboratory analytic precision as estimated from two distinct programs from the College of American Pathologists.
    Platt R; Batsakis JG
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):578-80. PubMed ID: 7282644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intralaboratory performance and laboratorians' expectations for stat turnaround times. A College of American Pathologists Q-Probes study of four cerebrospinal fluid determinations.
    Howanitz PJ; Steindel SJ
    Arch Pathol Lab Med; 1991 Oct; 115(10):977-83. PubMed ID: 1898244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interinstitutional comparison of frozen section consultation in small hospitals: a College of American Pathologists Q-Probes study of 18,532 frozen section consultation diagnoses in 233 small hospitals.
    Novis DA; Gephardt GN; Zarbo RJ;
    Arch Pathol Lab Med; 1996 Dec; 120(12):1087-93. PubMed ID: 15456172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing at the patient's bedside.
    Jones BA
    Clin Lab Med; 1994 Sep; 14(3):473-91. PubMed ID: 7805342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interinstitutional comparison of frozen section turnaround time. A College of American Pathologists Q-Probes study of 32868 frozen sections in 700 hospitals.
    Novis DA; Zarbo RJ
    Arch Pathol Lab Med; 1997 Jun; 121(6):559-67. PubMed ID: 9199619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines on the use of blood glucose meters and nonmeter blood glucose reagent strips in hospitals. Committee on Monitoring Devices, Canadian Association of Pathologists.
    CMAJ; 1988 Jan; 138(1):27-9. PubMed ID: 3334914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol measurements. Quality assurance and medical usefulness interrelationships.
    Oxley DK
    Arch Pathol Lab Med; 1988 Apr; 112(4):387-91. PubMed ID: 3355339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program.
    Hayes TE; Brandt JT; Chandler WL; Eby CS; Kottke-Marchant K; Krishnan J; Lefkowitz JB; Olson JD; Rund CR; Van Cott EM; Cunningham MT
    Semin Thromb Hemost; 2006 Jul; 32(5):499-504. PubMed ID: 16862523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the laboratory accreditation programme of the College of American Pathologists.
    Abu-Amero KK
    East Mediterr Health J; 2002; 8(4-5):654-63. PubMed ID: 15603049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality assurance measurements in departments of pathology and laboratory medicine.
    Howanitz PJ
    Arch Pathol Lab Med; 1990 Nov; 114(11):1131-5. PubMed ID: 2241522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bedside monitoring of blood glucose: is better "bad"?
    Bachner P; Howanitz PJ; Jones BA
    Arch Pathol Lab Med; 1994 Jun; 118(6):594. PubMed ID: 8203999
    [No Abstract]   [Full Text] [Related]  

  • 40. Quality assurance for blood glucose monitoring. The balance of feasibility and standards.
    Walker EA
    Nurs Clin North Am; 1993 Mar; 28(1):61-70. PubMed ID: 8451217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.